What Sellas Life Sciences Group Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 0 | 0 |
| Total trades | 0 | 12 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 1,978,400 |
| Disposed | 0 | 309,458 |
| Net activity | +0 | +1,668,942 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Stergiou Andelos M. | President and CEO | Jun 16 | Grant / award · A | +1,065,000 | — | — | 1,759,183 |
| Kalin Katherine Bach | Director | Jan 07 | Grant / award · A | +50,000 | — | — | 154,400 |
| Cicic Dragan | SVP, Chief Development Officer | Jan 07 | Grant / award · A | +300,000 | — | — | 557,805 |
| Burns John Thomas | CFO | Jan 07 | Grant / award · A | +300,000 | — | — | 554,327 |
| Scheinberg David A | Director | Jan 07 | Grant / award · A | +50,000 | — | — | 73,082 |
| Van Nostrand Robert L | Director | Jan 07 | Grant / award · A | +50,000 | — | — | 82,900 |
| Varian John | Director | Jan 07 | Grant / award · A | +50,000 | — | — | 72,900 |
| Wasman Jane | Director | Jan 07 | Grant / award · A | +50,000 | — | — | 92,900 |
| Burns John Thomas | CFO | Dec 03 | Other Transaction · J | −58,592 | $1.50 | −$87.9K | 254,327 |
| Cicic Dragan | SVP, Chief Development Officer | Dec 03 | Other Transaction · J | −63,800 | $1.50 | −$95.7K | 257,805 |
| Stergiou Andelos M. | President and CEO | Dec 03 | Other Transaction · J | −187,066 | $1.50 | −$281K | 686,966 |
| Kalin Katherine Bach | Director | Nov 19 | Open-market buy · P | +63,400 | $1.59 | +$101K | 104,400 |
| Van Nostrand Robert L | Director | Jun 12 | Open-market buy · P | +10,000 | $1.48 | +$14.8K | 20,400 |
| Wasman Jane | Director | May 30 | Open-market buy · P | +20,000 | $1.69 | +$33.8K | 30,400 |
| Kalin Katherine Bach | Director | May 22 | Open-market buy · P | +20,000 | $1.80 | +$36K | 41,000 |
| Kalin Katherine Bach | Director | Jan 10 | Grant / award · A | +12,500 | — | — | 21,000 |
| Cicic Dragan | SVP, Chief Development Officer | Jan 10 | Grant / award · A | +81,300 | — | — | 309,628 |
| Cicic Dragan | SVP, Chief Development Officer | Jan 10 | Grant / award · A | +113,000 | — | — | 228,328 |
| Burns John Thomas | CFO | Jan 10 | Grant / award · A | +81,300 | — | — | 299,062 |
| Burns John Thomas | CFO | Jan 10 | Grant / award · A | +113,000 | — | — | 217,762 |
Loading...
